TANG CAPITAL MANAGEMENT LLC — Form 4 insider transactions

TANG CAPITAL MANAGEMENT LLC — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 $598 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 $4,080 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 $20,136 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 $1,241 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 $5,412 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 $25,697 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 $22,862 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 $14,837 SEC filing
2026-10-22 Buy Boundless Bio, Inc. 5,800 $2.40 $13,920 SEC filing
2026-10-20 Buy Boundless Bio, Inc. 220 $2.37 $521 SEC filing
2026-10-19 Buy Boundless Bio, Inc. 18,279 $2.33 $42,590 SEC filing
2026-10-19 Buy Boundless Bio, Inc. 12,790 $2.34 $29,929 SEC filing
2026-10-16 Buy Boundless Bio, Inc. 118,185 $2.34 $276,553 SEC filing
2026-08-26 Sell Boundless Bio, Inc. 18,300 $2.97 $54,351 SEC filing
2026-07-21 Buy Boundless Bio, Inc. 2,975 $2.44 $7,259 SEC filing
2026-07-20 Buy Boundless Bio, Inc. 1,623 $2.44 $3,960 SEC filing
2026-07-17 Buy Boundless Bio, Inc. 265 $2.44 $647 SEC filing
2026-07-17 Buy Fulcrum Therapeutics, Inc. 50,945 $3.52 $179,326 SEC filing
2026-07-16 Buy Fulcrum Therapeutics, Inc. 116,671 $3.56 $415,349 SEC filing
2026-07-16 Buy Boundless Bio, Inc. 18,491 $2.44 $45,118 SEC filing
2026-07-15 Buy Boundless Bio, Inc. 1,600 $2.44 $3,904 SEC filing
2026-07-14 Buy Boundless Bio, Inc. 43,878 $2.43 $106,624 SEC filing
2026-07-15 Buy Fulcrum Therapeutics, Inc. 107,377 $3.56 $382,262 SEC filing
2026-07-14 Buy Fulcrum Therapeutics, Inc. 75,952 $3.58 $271,908 SEC filing
2026-07-14 Buy Fulcrum Therapeutics, Inc. 53,651 $3.56 $190,998 SEC filing
2026-07-13 Buy Fulcrum Therapeutics, Inc. 12,966 $3.54 $45,900 SEC filing
2026-07-13 Buy Boundless Bio, Inc. 48,211 $2.42 $116,671 SEC filing
2026-07-10 Buy Boundless Bio, Inc. 43,367 $2.43 $105,382 SEC filing
2026-07-09 Buy Boundless Bio, Inc. 7 $2.48 $17 SEC filing
2026-07-08 Buy Boundless Bio, Inc. 14,338 $2.46 $35,271 SEC filing
2026-07-07 Buy Boundless Bio, Inc. 15,810 $2.48 $39,209 SEC filing
2026-07-06 Buy Boundless Bio, Inc. 27,062 $2.49 $67,384 SEC filing
2026-07-02 Buy Boundless Bio, Inc. 9,821 $2.49 $24,454 SEC filing
2026-07-01 Buy Boundless Bio, Inc. 71,612 $2.49 $178,314 SEC filing
2026-06-30 Buy Boundless Bio, Inc. 100 $2.50 $250 SEC filing
2026-06-30 Buy Boundless Bio, Inc. 25,930 $2.54 $65,862 SEC filing
2026-06-29 Buy Boundless Bio, Inc. 777 $2.48 $1,927 SEC filing
2026-06-29 Buy Boundless Bio, Inc. 63,985 $2.47 $158,043 SEC filing
2026-06-26 Buy Boundless Bio, Inc. 134 $2.54 $340 SEC filing
2026-06-26 Buy Boundless Bio, Inc. 75,047 $2.55 $191,370 SEC filing
2026-06-25 Buy Boundless Bio, Inc. 510 $2.56 $1,306 SEC filing
2026-06-25 Buy Boundless Bio, Inc. 145,880 $2.48 $361,782 SEC filing
2026-06-02 Buy Aurinia Pharmaceuticals Inc. 206,005 $15.28 $3,147,756 SEC filing
2026-06-01 Buy Aurinia Pharmaceuticals Inc. 99 $15.34 $1,519 SEC filing
2026-06-01 Buy Aurinia Pharmaceuticals Inc. 343,521 $15.28 $5,249,001 SEC filing
2026-05-29 Buy Aurinia Pharmaceuticals Inc. 262,682 $15.31 $4,021,661 SEC filing
2026-05-29 Buy Aurinia Pharmaceuticals Inc. 2,299 $15.35 $35,290 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →